Santa Monica's Bay Cities deli closed for health code violations
Santa Monica's Bay Cities Italian Deli & Bakery closed on Wednesday after inspectors found several health code violations, mainly a vermin infestation.
The Los Angeles County Department of Public Health described the vermin infestation violation as "major" in its reasoning for Bay Cities' closure.
Inspectors also listed nine other violations, totaling 24 points. According to the department's health grading system for restaurants, markets and bakeries, Bay Cities would have received a C rating.
"All food facilities that have a critical violation may be subject to closure regardless of the score received on the inspection report," public health officials wrote on the department's website. "Food facilities that score below seventy percent (70%) twice within a twelve (12) month period are subject to closure and further legal action."
It's unclear when Bay Cities will reopen. According to public health records, the market has failed one other inspection in the last five years. In the September 2024 public health report, inspectors found two critical violations for hand washing and improper sanitization of utensils and equipment.
Public health officials said they carried out the inspection after someone got sick after eating the market's signature "Godmother sandwich."
The family-owned market opened in 1925 and gained a following for its sandwiches.
"When you dine at our Italian deli and bakery in Santa Monica, California, you can expect the highest quality food made with the freshest ingredients, along with friendly, personal customer service," the market wrote on its website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
24 minutes ago
- New York Times
Kennedy's New Vaccine Advisers Helped Lawyers Raise Doubts About Their Safety
Three of the new advisers appointed by Health Secretary Robert F. Kennedy Jr. to guide the government on immunization policy took part in lawsuits casting doubt on the safety or efficacy of vaccines, public records show. In dismissing all 17 members of an influential Centers for Disease Control and Prevention advisory panel on Monday, Mr. Kennedy cited what he said was a history of conflicts of interest that he claimed made those experts a 'rubber stamp' on approving vaccines. But adding members who assisted in legal cases that were either against vaccine makers or that suggested widespread vaccine-caused harm raises questions about a different form of potential bias. While the legal involvement of the three new panelists does not appear to violate the rules, critics of Mr. Kennedy said it created the appearance of a conflict. 'He's invoking the language of ethics and integrity to get rid of these experts and now is installing people who may have their own biases — that he apparently does not want to recognize,' said Kathleen Clark, a law professor and ethics expert at Washington University in St. Louis. One of Mr. Kennedy's appointees, Vicky Pebsworth, is a nurse who serves on the board of a nonprofit dedicated to raising awareness about vaccine injuries. She certified to a court that, in her professional opinion, a survey of families of unvaccinated children supported the hypothesis that a rise in the number of recommended childhood vaccines explained an epidemic of chronic disease. Mr. Kennedy has espoused the same theory. Another, Dr. Robert Malone, a physician and biochemist whose criticism of mRNA Covid-19 vaccines catapulted him into the spotlight during the pandemic, was a paid expert witness on behalf of company whistle-blowers who claimed that Merck, one of the nation's largest vaccine manufacturers, had covered up evidence casting doubt on the effectiveness of the mumps vaccine. Want all of The Times? Subscribe.
CBS News
31 minutes ago
- CBS News
First measles case confirmed in Dallas County, officials say
Dallas County has confirmed its first case of measles in 2025, health officials announced. The patient, a woman in her mid-20s, was contagious from May 30 through June 7 and visited two public locations in Plano during that time. Vaccinated but still infected A handout photo from the CDC shows a measles rash on a child's face. U.S. Centers for Disease Control and Prevention Dr. Phil Huang, director of Dallas County Health and Human Services, said the woman was fully vaccinated, which makes the case rare. "The person is in her mid-20s. She was actually fully vaccinated, which is quite unusual, rare," Huang said. Despite the diagnosis, the woman has not shown symptoms. "She's actually asymptomatic. No symptoms at this point, and she's doing well," Huang said. Public exposure sites identified Officials said the woman visited Lemma Coffee in Plano from 9 a.m. to 12 p.m. on May 31 and First Baptist Plano from 1 to 5:30 p.m. on June 1. Health officials urge vaccination Huang emphasized the importance of vaccination and monitoring for symptoms. "The best thing everyone can do is to get up to date on the vaccine. If not, then monitor for any symptoms if you went to those places," he said. Recognizing measles symptoms Measles symptoms can include fever, runny nose, bloodshot eyes and a rash that starts at the hairline and spreads downward. "Measles was declared eliminated in the United States in 2000 because we have good vaccination rates," Huang said. "The vaccine is very safe and effective. It's about 97% effective." Unvaccinated at higher risk Health officials warn that unvaccinated individuals are most at risk. Dr. Carla Garcia Carreno, director at Children's Health Plano, said complications can be serious. "About 20% of people may need to be hospitalized. About 5% of people will develop pneumonia or respiratory complications. About 8% of people may develop diarrhea," she said. No link to West Texas outbreak Dallas County's case does not appear to be connected to the ongoing measles outbreak in West Texas.
Medscape
an hour ago
- Medscape
Rapid Rx Quiz: Sleep Apnea Devices
CPAP (continuous positive airway pressure), along with other devices such as APAP (automatic positive airway pressure) and BiPAP (bilevel positive airway pressure), have been the mainstay in treating obstructive sleep apnea (OSA) for decades. Despite their proven effectiveness, patients can struggle with discomfort or intolerance of these treatments, which can lead to suboptimal adherence. As a result, alternative devices have been developed to address the needs of individuals who cannot tolerate traditional therapy, offering other approaches to maintaining airway patency and managing related health outcomes. What do you know about devices for sleep apnea? Test yourself with this brief quiz. Current clinical practice guidelines from the AASM recommend the use of either APAP or CPAP in OSA treatment in adults. No clinically meaningful differences were found in outcomes of APAP treatment vs CPAP treatment, and benefits and harm were similar between the two modalities. Patient tolerance and symptom response should guide the choice of one over the other. APAP or CPAP are recommended over BiPAP for initial treatment of OSA in adults. BiPAP might provide an expiratory pressure that is too low to prevent obstructive breathing. However, BiPAP therapy for OSA might be appropriate in certain patients, such as those who have not responded to treatment with APAP and CPAP or those who require very high pressures (> 20 cm H2O). Learn more about sleep-disordered breathing and CPAP. According to current guidelines from the AADSM, patients should be seen by their dentist for a follow-up evaluation within 30 days after appliance insertion. During the first year, patients should be re-evaluated every 6 months, and at least once annually after that to assess treatment efficacy and adherence. At these visits, the treating dentist should use the same standardized tools and questionnaires employed during the initial evaluation to monitor symptoms and treatment response. Adjustment of the oral appliance depends on several factors, including the patient's mandibular range of motion, OSA severity, comfort, and observed changes in symptoms. A collaborative protocol between the treating dentist and the patient's medical provider should be in place to support objective and coordinated assessment. Learn more about oral appliance therapy for OSA. The implantable hypoglossal nerve stimulator received US Food and Drug Administration (FDA) approval in 2014 for the treatment of moderate to severe OSA in patients who have not responded to or cannot tolerate PAP therapy. As hypoglossal nerve stimulation has been shown to be most efficacious in those with a BMI < 32, an adult with moderate OSA and a BMI of 28 probably would be a good candidate for this treatment approach. Hypoglossal nerve stimulation has not been approved in patients aged < 18 years, so a boy aged 15 years would not be a candidate. Also, the stimulator is contraindicated in patients with central sleep apnea. The safety of hypoglossal nerve stimulation has not been established in pregnant patients and should not be undertaken. Learn more about upper airway evaluation in snoring and OSA. An external tongue muscle stimulator device was cleared by the FDA in 2020. Intended for use 20 min/d for 6 weeks and then twice per week subsequently, the device requires far less patient time commitment than some other OSA therapy devices. The tongue muscle stimulator is designed to be used while awake for 20-minute increments. It is indicated for snoring and mild OSA and is not indicated to treat OSA with an apnea-hypopnea index (AHI) > 15. The device is approved only for adults aged ≥ 18 years. Learn more about macroglossia. EPAP devices are noninvasive, valve-based devices for the treatment of mild to moderate OSA. They function by creating resistance during expiration, generating back pressure that helps keep the upper airway open during sleep. Unlike CPAP therapy, which provides constant pressure during both inhalation and exhalation, EPAP devices are passive and provide pressure only during expiration. These devices do not require batteries or power sources. They resemble nasal pillows, like those used with many CPAP machines. Unlike oral appliances, EPAP devices do not require custom fitting. Monthly calibration is also not needed. Learn more about pathologic conditions associated with OSA.
